PROFILE |
 |
Lonza Group is pro-life ... science. Spun off by Switzerland's diversified industrial firm Alusuisse Lonza Group (Algroup), Lonza Group makes fine chemicals, intermediates, and additives. Lonza plans to sell its polymer and energy businesses to focus on its life sciences (biotechnology and fine chemicals) units. Its Organic Fine and Performance Chemicals segment (about 60% of sales) makes products used in agrochemicals, pharmaceuticals, dyes, pigments, and adhesives. It's Exclusive Synthesis and Biotechnology unit (about 40%) makes agrochemicals and also biocides and oleochemicals used in personal-care, water-treatment, and wood-preservation products. BZ Gruppe Holding Aktiengesellschaft owns about 20% of Lonza Group.
COMPETITION |
 |
BASF Aktiengesellschaft (BF)
Rhodia SA (RHA)
Rohm and Haas Company (ROH)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 1,525.80
1-Yr. Sales Growth: 11.2%
Employees: 5,987
Revenue per employee: $254,852.18
KEY PEOPLE |
 |
R. Helmut Rupp
CEO
CONTACT INFO |
 |
Münchensteinerstr. 38
CH-4038 Basel, Switzerland
Phone: 41-41-61-316-8111
Fax: 41-41-61-316-9111
Online: Web Site
|